Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -20.79 | N/A |
| PEG Ratio (TTM) | 0.07 | N/A |
| P/S Ratio (TTM) | 0.88 | N/A |
| P/B Ratio (TTM) | 1.07 | N/A |
| P/FCF Ratio (TTM) | -1,169.79 | N/A |
| Price to 5YR AVG Earnings Ratio | -16.79 | N/A |
| Price to 5YR AVG FCF Ratio | -15.07 | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -3.90% | N/A |
| ROE (TTM) | -5.08% | N/A |
| Net Profit Margin (TTM) | -4.24% | N/A |
| ROIC 5YR AVG | -15.40% | N/A |
Growth (5%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -406.09% | -398.33% | -209.67% |
| Revenue | -10.01% | -6.86% | 10.39% |
| Net Income | -420.33% | -418.40% | -223.68% |
| Cash Flow | -41.73% | -49.70% | -78.18% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.32 | N/A |
| Quick Ratio (TTM) | 1.83 | N/A |
| D/E Ratio (TTM) | 0.06 | N/A |
| Interest Coverage (TTM) | -64.54 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 3.75 | N/A |
| LTL to 5YR AVG FCF | -0.27 | N/A |
| Shares Outstanding Growth 5YR AVG | 6.18% | N/A |